Shaked G M, Fridlander G, Meiner Z, Taraboulos A, Gabizon R
Department of Neurology, Hadassah University Hospital, Jerusalem 91120, Israel.
J Biol Chem. 1999 Jun 18;274(25):17981-6. doi: 10.1074/jbc.274.25.17981.
PrPSc, an abnormal isoform of PrPC, is the only known component of the prion, an agent causing fatal neurodegenerative disorders such as bovine spongiform encephalopathy (BSE) and Creutzfeldt-Jakob disease (CJD). It has been postulated that prion diseases propagate by the conversion of detergent-soluble and protease-sensitive PrPC molecules into protease-resistant and insoluble PrPSc molecules by a mechanism in which PrPSc serves as a template. We show here that the chemical chaperone dimethyl sulfoxide (Me2SO) can partially inhibit the aggregation of either PrPSc or that of its protease-resistant core PrP27-30. Following Me2SO removal by methanol precipitation, solubilized PrP27-30 molecules aggregated into small and amorphous structures that did not resemble the rod configuration observed when scrapie brain membranes were extracted with Sarkosyl and digested with proteinase K. Interestingly, aggregates derived from Me2SO-solubilized PrP27-30 presented less than 1% of the prion infectivity obtained when the same amount of PrP27-30 in rods was inoculated into hamsters. These results suggest that the conversion of PrPC into protease-resistant and detergent-insoluble PrP molecules is not the only crucial step in prion replication. Whether an additional requirement is the aggregation of newly formed proteinase K-resistant PrP molecules into uniquely structured aggregates remains to be established.
朊病毒蛋白(PrPSc)是朊蛋白前体(PrPC)的异常异构体,是已知的唯一朊病毒成分,朊病毒是一种可导致致命神经退行性疾病的病原体,如牛海绵状脑病(BSE)和克雅氏病(CJD)。据推测,朊病毒疾病通过一种机制传播,即去污剂可溶且蛋白酶敏感的PrPC分子通过以PrPSc为模板的机制转化为蛋白酶抗性且不溶的PrPSc分子。我们在此表明,化学伴侣二甲基亚砜(Me2SO)可部分抑制PrPSc或其蛋白酶抗性核心PrP27-30的聚集。通过甲醇沉淀去除Me2SO后,溶解的PrP27-30分子聚集成小的无定形结构,这些结构与用十二烷基肌氨酸钠提取瘙痒病脑膜并用蛋白酶K消化时观察到的杆状结构不同。有趣的是,从Me2SO溶解的PrP27-30衍生的聚集体所呈现的朊病毒感染性不到将相同量的杆状PrP27-30接种到仓鼠中所获得的感染性的1%。这些结果表明,PrPC转化为蛋白酶抗性和去污剂不溶性PrP分子不是朊病毒复制的唯一关键步骤。新形成的蛋白酶K抗性PrP分子是否还需要聚集成独特结构的聚集体仍有待确定。